Market Exclusive

Analyst Upgrades – NASDAQ:INSM – Insmed (NASDAQ:INSM) Stock Gets Upgraded By Credit Suisse Group from Neutral to Outperform

Analyst Ratings For NASDAQ:INSM – Insmed (NASDAQ:INSM)

Today, NASDAQ:INSM – Insmed (NASDAQ:INSM) stock received an upgrade by Credit Suisse Group from Neutral to Outperform with a price target of $31.00.

Some recent analyst ratings include

Recent Insider Trading Activity For NASDAQ:INSM – Insmed (NASDAQ:INSM)
NASDAQ:INSM – Insmed (NASDAQ:INSM) has insider ownership of 3.88% and institutional ownership of 99.07%.

Recent Trading Activity for NASDAQ:INSM – Insmed (NASDAQ:INSM)
Shares of NASDAQ:INSM – Insmed closed the previous trading session at with 269854 shares trading hands.

Exit mobile version